These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30182776)

  • 21. The application of existing genotoxicity methodologies for grouping of nanomaterials: towards an integrated approach to testing and assessment.
    Verdon R; Stone V; Murphy F; Christopher E; Johnston H; Doak S; Vogel U; Haase A; Kermanizadeh A
    Part Fibre Toxicol; 2022 May; 19(1):32. PubMed ID: 35525968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grouping of nanomaterials for risk assessment.
    Bolt HM
    Arch Toxicol; 2014 Dec; 88(12):2077-8. PubMed ID: 25413730
    [No Abstract]   [Full Text] [Related]  

  • 23. Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project.
    Escher SE; Kamp H; Bennekou SH; Bitsch A; Fisher C; Graepel R; Hengstler JG; Herzler M; Knight D; Leist M; Norinder U; Ouédraogo G; Pastor M; Stuard S; White A; Zdrazil B; van de Water B; Kroese D
    Arch Toxicol; 2019 Dec; 93(12):3643-3667. PubMed ID: 31781791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotoxicity of nanomaterials: refining strategies and tests for hazard identification.
    Pfuhler S; Elespuru R; Aardema MJ; Doak SH; Maria Donner E; Honma M; Kirsch-Volders M; Landsiedel R; Manjanatha M; Singer T; Kim JH
    Environ Mol Mutagen; 2013 May; 54(4):229-39. PubMed ID: 23519787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Criteria for grouping of manufactured nanomaterials to facilitate hazard and risk assessment, a systematic review of expert opinions.
    Landvik NE; Skaug V; Mohr B; Verbeek J; Zienolddiny S
    Regul Toxicol Pharmacol; 2018 Jun; 95():270-279. PubMed ID: 29614343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancing the science on chemical classes.
    Maffini MV; Rayasam SDG; Axelrad DA; Birnbaum LS; Cooper C; Franjevic S; MacRoy PM; Nachman KE; Patisaul HB; Rodgers KM; Rossi MS; Schettler T; Solomon GM; Woodruff TJ
    Environ Health; 2023 Jan; 21(Suppl 1):120. PubMed ID: 36635752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of Bayesian networks for hazard ranking of nanomaterials to support human health risk assessment.
    Marvin HJ; Bouzembrak Y; Janssen EM; van der Zande M; Murphy F; Sheehan B; Mullins M; Bouwmeester H
    Nanotoxicology; 2017 Feb; 11(1):123-133. PubMed ID: 28044458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Safety of medicinal nanoproducts: new areas of toxicological research].
    Grudziński IP
    Rocz Panstw Zakl Hig; 2011; 62(3):239-46. PubMed ID: 22171512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supporting read-across using biological data.
    Zhu H; Bouhifd M; Donley E; Egnash L; Kleinstreuer N; Kroese ED; Liu Z; Luechtefeld T; Palmer J; Pamies D; Shen J; Strauss V; Wu S; Hartung T
    ALTEX; 2016; 33(2):167-82. PubMed ID: 26863516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refinement of the selection of physicochemical properties for grouping and read-across of nanoforms.
    Loosli F; Rasmussen K; Rauscher H; Cross RK; Bossa N; Peijnenburg W; Arts J; Matzke M; Svendsen C; Spurgeon D; Clausen PA; Ruggiero E; Wohlleben W; von der Kammer F
    NanoImpact; 2022 Jan; 25():100375. PubMed ID: 35559881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Derivation of thresholds for inhaled chemically reactive irritants: Searching for substance-specific common denominators for read-across prediction.
    Pauluhn J
    Regul Toxicol Pharmacol; 2022 Apr; 130():105131. PubMed ID: 35124139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An in-depth multi-omics analysis in RLE-6TN rat alveolar epithelial cells allows for nanomaterial categorization.
    Karkossa I; Bannuscher A; Hellack B; Bahl A; Buhs S; Nollau P; Luch A; Schubert K; von Bergen M; Haase A
    Part Fibre Toxicol; 2019 Oct; 16(1):38. PubMed ID: 31653258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to formulate hypotheses and IATAs to support grouping and read-across of nanoforms.
    Murphy FA; Johnston HJ; Dekkers S; Bleeker EAJ; Oomen AG; Fernandes TF; Rasmussen K; Jantunen P; Rauscher H; Hunt N; di Cristo L; Braakhuis HM; Haase A; Hristozov D; Wohlleben W; Sabella S; Stone V
    ALTEX; 2023; 40(1):125-140. PubMed ID: 35796348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward Good Read-Across Practice (GRAP) guidance.
    Ball N; Cronin MT; Shen J; Blackburn K; Booth ED; Bouhifd M; Donley E; Egnash L; Hastings C; Juberg DR; Kleensang A; Kleinstreuer N; Kroese ED; Lee AC; Luechtefeld T; Maertens A; Marty S; Naciff JM; Palmer J; Pamies D; Penman M; Richarz AN; Russo DP; Stuard SB; Patlewicz G; van Ravenzwaay B; Wu S; Zhu H; Hartung T
    ALTEX; 2016; 33(2):149-66. PubMed ID: 26863606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Grouping nanomaterials to predict their potential to induce pulmonary inflammation.
    Braakhuis HM; Oomen AG; Cassee FR
    Toxicol Appl Pharmacol; 2016 May; 299():3-7. PubMed ID: 26603513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance and Application of Read-Across - Mini Review of European Consensus Platform for Alternatives and Scandinavian Society for Cell Toxicology 2017 Workshop Session.
    Stuard SB; Heinonen T
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():37-41. PubMed ID: 29524304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards a nanospecific approach for risk assessment.
    Dekkers S; Oomen AG; Bleeker EA; Vandebriel RJ; Micheletti C; Cabellos J; Janer G; Fuentes N; Vázquez-Campos S; Borges T; Silva MJ; Prina-Mello A; Movia D; Nesslany F; Ribeiro AR; Leite PE; Groenewold M; Cassee FR; Sips AJ; Dijkzeul A; van Teunenbroek T; Wijnhoven SW
    Regul Toxicol Pharmacol; 2016 Oct; 80():46-59. PubMed ID: 27255696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A strategy for structuring and reporting a read-across prediction of toxicity.
    Schultz TW; Amcoff P; Berggren E; Gautier F; Klaric M; Knight DJ; Mahony C; Schwarz M; White A; Cronin MT
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):586-601. PubMed ID: 26003513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An integrated approach to testing and assessment of high aspect ratio nanomaterials and its application for grouping based on a common mesothelioma hazard.
    Murphy F; Dekkers S; Braakhuis H; Ma-Hock L; Johnston H; Janer G; di Cristo L; Sabella S; Jacobsen NR; Oomen AG; Haase A; Fernandes T; Stone V
    NanoImpact; 2021 Apr; 22():100314. PubMed ID: 35559971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices.
    Bouwmeester H; Lynch I; Marvin HJ; Dawson KA; Berges M; Braguer D; Byrne HJ; Casey A; Chambers G; Clift MJ; Elia G; Fernandes TF; Fjellsbø LB; Hatto P; Juillerat L; Klein C; Kreyling WG; Nickel C; Riediker M; Stone V
    Nanotoxicology; 2011 Mar; 5(1):1-11. PubMed ID: 21417684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.